Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Thrombophilia, Left Ventricular Dysfunction and Intracardiac Thrombi in Children

  • Abu-Kishk, Ibrahim (Pediatric Division, Assaf Harofeh Medical Center, Zerifin, Israel, Affiliated to the Sackler Faculty of Medicine) ;
  • Baram, Shaul (Pediatric Cardiology Unit, Assaf Harofeh Medical Center, Zerifin, Israel, Affiliated to the Sackler Faculty of Medicine) ;
  • Kozer, Eran (Pediatric Division, Assaf Harofeh Medical Center, Zerifin, Israel, Affiliated to the Sackler Faculty of Medicine) ;
  • Klin, Baruch (Department of Pediatric Surgery, Assaf Harofeh Medical Center, Zerifin, Israel, Affiliated to the Sackler Faculty of Medicine) ;
  • Eshel, Gideon (Pediatric Division, Assaf Harofeh Medical Center, Zerifin, Israel, Affiliated to the Sackler Faculty of Medicine)
  • Published : 2011.08.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: Reports on the incidence of intracardiac thrombi (ICT) have increased over the last few decades, but ICT are still relatively rare among children. Left ventricular systolic dysfunction and dilatation may contribute to the formation of ICT, especially when a hypercoagulable state exists. The aim of this study was to describe the incidence of ICT in children suffering from cardiac failure with left ventricular dysfunction and to identify risk factors on admission for developing ICT. Subjects and Methods: We conducted a retrospective chart review of children up to 18 years of age admitted to the Pediatric Intensive Care Unit due to cardiac failure with left ventricular dysfunction between January 1, 2003 and December 31, 2008. Results: Twenty-one patients were admitted with clinical signs of cardiac failure and echocardiographic findings compatible with dilated cardiomyopathy or acute myocarditis. Dilated cardiomyopathy was diagnosed in 11 patients (52%). Adenoviruses and enteroviruses were suspected to be the cause of acute myocarditis in 5 cases. The personal or family history of hypercoagulable states were obtained from 19 out of 21 patients (90%). Among patients with a hypercoagulable state, 3 out of 7 developed ICT compared with none out of 12 among patients without hypercoagulability (p=0.043). Two of these 3 patients experienced an embolic event. Conclusion: Cardiac failure with left ventricular dysfunction may predispose the patient to ICT and increase the risk of thromboembolism, especially when an underlying hypercoagulable state exists. The hypercoagulable state must be carefully evaluated on admission in these patients.

Keywords

References

  1. Atalay S, Akar N, Tutar HE, Yilmaz E. Factor V 1691 G-A mutation in children with intracardiac thrombosis: a prospective study. Acta Paediatr 2002;91:168-71. https://doi.org/10.1111/j.1651-2227.2002.tb01690.x
  2. Atalay S, Imamoglu A, Ikizler C, Uluoglu O, Ocal B. Mitral valve and left ventricular thrombi in an infant with acquired protein C deficiency. Angiology 1995;46:87-90. https://doi.org/10.1177/000331979504600112
  3. Favara BE, Franciosi RA, Butterfield LJ. Disseminated intravascular and cardiac thrombosis of the neonate. Am J Dis Child 1974;127:197-204.
  4. Gurgey A, Ozyurek E, Gümrük F, et al. Thrombosis in children with cardiac pathology: frequency of factor V Leiden and prothrombin G20210A mutations. Pediatr Cardiol 2003;24:244-8. https://doi.org/10.1007/s00246-002-0170-z
  5. Ozkutlu S, Ozbarlas N, Ozme S, Saraclar M, Gogus S, Demircin M. Intracardiac thrombosis diagnosed by echocardiography in childhood: predisposing and etiological factors. Int J Cardiol 1993;40:251-6. https://doi.org/10.1016/0167-5273(93)90008-5
  6. Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow's triade revisited. J Am Coll Cardiol 1999;33:1424-6. https://doi.org/10.1016/S0735-1097(99)00033-9
  7. Meltzer RS, Visser CA, Fuster V. Intracardiac thrombi and systemic embolization. Ann Intern Med 1986;104:689-98. https://doi.org/10.7326/0003-4819-104-5-689
  8. Treasure CB, Vita JA, Cox DA, et al. Endothelium-dependent dilation of coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990;81:772-9. https://doi.org/10.1161/01.CIR.81.3.772
  9. Kadar K, Hartyanszky I, Kiraly L, Bendig L. Right heart thrombus in infants and children. Pediatr Cardiol 1991;12:24-7. https://doi.org/10.1007/BF02238494
  10. Ross P Jr, Ehrenkranz R, Kleinman CS, Seashore JH. Thrombus associated with central venous catheters in infants and children. J Pediatr Surg 1989;24:253-6. https://doi.org/10.1016/S0022-3468(89)80006-5
  11. Tegeler CH, Downes TR. Thrombosis and the heart. Semin Neurol 1991;11:339-52. https://doi.org/10.1055/s-2008-1041239
  12. Khairy P, Fernandes SM, Mayer JE Jr, et al. Long-term survival, mo-des of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008;117:85-92. https://doi.org/10.1161/CIRCULATIONAHA.107.738559
  13. Schiller NB, Shah PM, Crawford, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
  14. Lang RM, Bierig M, Devereux RB, et al. Recommendations for ch-amber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63. https://doi.org/10.1016/j.echo.2005.10.005
  15. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-16. https://doi.org/10.1161/CIRCULATIONAHA.106.174287
  16. Gunthard J, Stocker F, Bolz D, et al. Dilated cardiomyopathy and thrombo-embolism. Eur J Pediatr 1997;156:3-6. https://doi.org/10.1007/s004310050541
  17. Kohlhase B, Vielhaber H, Kehl HG, Kececioglu D, Koch HG, No-wak-Gottl U. Thromboembolism and resistance of activated protein C in children with underlying cardiac disease. J Pediatr 1996;129: 677-9. https://doi.org/10.1016/S0022-3476(96)70149-X
  18. Suskan E, Kemahli S, Atalay S, Ertogan F, Karademir S. Intracardiac thrombosis associated with acquired protein C deficiency. Eur J Pediatr 1994;153:862-3.
  19. Alioglu B, Avci Z, Tokel K, Atac FB, Ozbek N. Thrombosis in children with cardiac pathology: analysis of acquired and inherited risk factors. Blood Coagul Fibrinolysis 2008;19:294-304. https://doi.org/10.1097/MBC.0b013e3282fe73b1
  20. Hochster H, Wasserheit C, Speyer J. Cardiotoxicity and cardioprotection during chemotherapy. Curr Opin Oncol 1995;7:304-9. https://doi.org/10.1097/00001622-199507000-00002
  21. Martin M, Diaz-Rubio E, Furio V, Blazquez J, Almenarez J, Farina J. Lethal cardiac toxicity after cisplatin and 5-fluorouracil chemotherapy. Report of a case with necropsy study. Am J Clin Oncol 1989;12: 229-34. https://doi.org/10.1097/00000421-198906000-00010
  22. Misset B, Escudier B, Leclercq B, Rivara D, Rougier P, Nitenberg G. Acute myocardiotoxicity during 5-fluorouracil therapy. Intensive Care Med 1990;16:210-1. https://doi.org/10.1007/BF01724805
  23. Sasson Z, Morgan CD, Wang B, Thomas G, MacKenzie B, Platts ME. 5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation. Can J Cardiol 1994;10:861-4.
  24. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, proth-rombotic mutations, and the risk of venous thrombosis. JAMA 2005;293;715-22. https://doi.org/10.1001/jama.293.6.715
  25. Schreijer AJ, Cannegieter SC, Meijers JC, Middeldorp S, Buller HR, Rosendaal FR. Activation of coagulation system during air travel: a crossover study. Lancet 2006;367:832-8. https://doi.org/10.1016/S0140-6736(06)68339-6
  26. Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991; 122:763-71. https://doi.org/10.1016/0002-8703(91)90523-K
  27. Ripley TL, Nutescu E. Anticoagulation in patients with heart failure and normal sinus rhythm. Am J Health Syst Pharm 2009;66:134-41. https://doi.org/10.2146/ajhp080047
  28. Monagle P, Chan A, Chalmers E, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133(6 Suppl):887S-968S. https://doi.org/10.1378/chest.08-0762

Cited by

  1. Surgical Thrombectomy of Two Left Ventricular Thrombi in a Child With Acute Myocarditis vol.131, pp.4, 2011, https://doi.org/10.1542/peds.2012-1185